< Back to situations

[ORGANIZATION]

Germed

Featured in 3 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [BR] [PY] [FR]

Brazil ANVISA expands product safety enforcement

38 clusters · 270 sources · last updated

Latest: Anvisa bans irregular insulin and peptide sales in Brazil

Since May 2026, Brazil’s National Health Surveillance Agency (ANVISA) has intensified enforcement of sanitary rules for pharmaceuticals, cosmetics, and consumer goods. Early actions included suspending batches of statins

[QUIET] [HEALTH] [BR]

Semaglutide regulatory approvals and pricing in Brazil

8 clusters · 112 sources · last updated

Latest: Brazil expands access to obesity and diabetes treatments

Brazil’s National Health Surveillance Agency (Anvisa) has expanded the domestic market for semaglutide, a medication used to treat type 2 diabetes and weight loss. Initially, Anvisa registered five new semaglutide inject